Ultraflex™ Tracheobronchial Stent System— 510(k) K230269

Substantially Equivalent

Boston Scientific Corporation

FDA 510(k) clearance K230269 for Ultraflex™ Tracheobronchial Stent System, Substantially Equivalent on 2023-07-14. Applicant: Boston Scientific Corporation.

Clearance details

Applicant
Boston Scientific Corporation
Product code
Code JCT
Advisory panel
General, Plastic Surgery
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Special
Location
Marlboro, MA, US
Download summary PDFView on FDA.gov ↗

Adverse events under product code JCT

product code JCT
Death
20
Injury
211
Other
1
Total
232

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.